These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 39180599)
1. Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer. Andrew J; Ezra-Manicum AL; Witika BA EJNMMI Radiopharm Chem; 2024 Aug; 9(1):62. PubMed ID: 39180599 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers. Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI Front Chem; 2022; 10():830133. PubMed ID: 35494646 [TBL] [Abstract][Full Text] [Related]
4. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments. Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091 [TBL] [Abstract][Full Text] [Related]
5. Applications of Nanoparticles Probes for Prostate Cancer Imaging and Therapy. Gao T; Bi A; Yang S; Liu Y; Kong X; Zeng W Adv Exp Med Biol; 2018; 1096():99-115. PubMed ID: 30324350 [TBL] [Abstract][Full Text] [Related]
6. Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy. He M; Cao Y; Chi C; Zhao J; Chong E; Chin KXC; Tan NZV; Dmitry K; Yang G; Yang X; Hu K; Enikeev M Front Immunol; 2023; 14():1265751. PubMed ID: 37795091 [TBL] [Abstract][Full Text] [Related]
7. Current progress of nanomedicine for prostate cancer diagnosis and treatment. Zhao J; Zhang C; Wang W; Li C; Mu X; Hu K Biomed Pharmacother; 2022 Nov; 155():113714. PubMed ID: 36150309 [TBL] [Abstract][Full Text] [Related]
8. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. Pranav ; Laskar P; Jaggi M; Chauhan SC; Yallapu MM J Adv Res; 2023 Sep; 51():197-217. PubMed ID: 36368516 [TBL] [Abstract][Full Text] [Related]
9. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review. Upadhyay TK; Ali MI; Khan F; Goel H; Mathur M; Goyal K; Moin S; Pandey P; Tanwar P; Sharangi AB; Gautam SDC; Kapdi JK; Patel KI; Patel MV; Parmar AM; Kamal MA Curr Med Chem; 2022; 29(24):4170-4184. PubMed ID: 34939536 [TBL] [Abstract][Full Text] [Related]
11. The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment. Andoh V; Ocansey DKW; Naveed H; Wang N; Chen L; Chen K; Mao F Int J Nanomedicine; 2024; 19():6099-6126. PubMed ID: 38911500 [TBL] [Abstract][Full Text] [Related]
12. PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future? Sallam M; Nguyen NT; Sainsbury F; Kimizuka N; Muyldermans S; Benešová-Schäfer M Theranostics; 2024; 14(8):3043-3079. PubMed ID: 38855174 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O EPMA J; 2020 Sep; 11(3):399-418. PubMed ID: 32843909 [TBL] [Abstract][Full Text] [Related]
14. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy. Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674 [TBL] [Abstract][Full Text] [Related]
15. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398 [TBL] [Abstract][Full Text] [Related]
16. The Potential Roles of Radionanomedicine and Radioexosomics in Prostate Cancer Research and Treatment. Bakht MK; Oh SW; Hwang DW; Lee YS; Youn H; Porter LA; Cheon GJ; Kwak C; Lee DS; Kang KW Curr Pharm Des; 2017; 23(20):2976-2990. PubMed ID: 28215159 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in nanomaterials for prostate cancer detection and diagnosis. Hu Y; Lv S; Wan J; Zheng C; Shao D; Wang H; Tao Y; Li M; Luo Y J Mater Chem B; 2022 Jul; 10(26):4907-4934. PubMed ID: 35712990 [TBL] [Abstract][Full Text] [Related]
18. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering. Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218 [TBL] [Abstract][Full Text] [Related]
19. Nanotechnology: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489 [TBL] [Abstract][Full Text] [Related]
20. The Emergence of Nanotechnology in the Prognosis and Treatment of Myocardial Infarctions. Sharma I; Bhardwaj S; Karwasra R; Kaushik D; Sharma S Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]